Literature DB >> 26149919

Mitochondrial decline precedes phenotype development in the complement factor H mouse model of retinal degeneration but can be corrected by near infrared light.

Karin C Calaza1, Jaimie Hoh Kam2, Chris Hogg3, Glen Jeffery4.   

Abstract

Mitochondria produce adenosine triphosphate (ATP), critical for cellular metabolism. ATP declines with age, which is associated with inflammation. Here, we measure retinal and brain ATP in normal C57BL/6 and complement factor H knockout mice (Cfh(-/-)), which are proposed as a model of age-related macular degeneration. We show a significant premature 30% decline in retinal ATP in Cfh(-/-) mice and a subsequent shift in expression of a heat shock protein that is predominantly mitochondrial (Hsp60). Changes in Hsp60 are associated with stress and neuroprotection. We find no differences in brain ATP between C57BL/6 and Cfh(-/-) mice. Near infrared (NIR) increases ATP and reduces inflammation. ATP decline in Cfh(-/-) mice was corrected with NIR which also shifted Hsp60 labeling patterns. ATP decline in Cfh(-/-) mice occurs before inflammation becomes established and photoreceptor loss occurs and may relate to disease etiology. However, ATP levels were corrected with NIR. In summary, we provide evidence for a mitochondrial basis for this disease in mice and correct this with simple light exposure known to improve mitochondrial function.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  670 nm; AMD; ATP; Aging; Retina

Mesh:

Substances:

Year:  2015        PMID: 26149919     DOI: 10.1016/j.neurobiolaging.2015.06.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  19 in total

1.  A hidden footprint: embryological origins of age related macular degeneration.

Authors:  Glen Jeffery; Sobha Sivaprasad
Journal:  Eye (Lond)       Date:  2019-04-17       Impact factor: 3.775

2.  Effects of light on aging and longevity.

Authors:  Jie Shen; John Tower
Journal:  Ageing Res Rev       Date:  2019-05-30       Impact factor: 10.895

3.  Light-Emitting Diode Laser Therapy for Hyperoxia-Induced Retinal Abnormalities.

Authors:  Maha Sabry Abd Eldaiem; Salwa Abdelkawi Ahmed; Aziza Abdelmonem Elsaeid; Aziza Ahmed Hassan; Dina Fouad Ghoneim; Ahlam Mohammed Ibrahim
Journal:  J Lasers Med Sci       Date:  2021-10-19

4.  Effect of Photobiomodulation in Suppression of Oxidative Stress on Retinal Pigment Epithelium.

Authors:  Jongmin Kim; Jae Yon Won
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

Review 5.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

6.  To unite or divide: mitochondrial dynamics in the murine outer retina that preceded age related photoreceptor loss.

Authors:  Jaimie Hoh Kam; Glen Jeffery
Journal:  Oncotarget       Date:  2015-09-29

7.  Aging retinal function is improved by near infrared light (670 nm) that is associated with corrected mitochondrial decline.

Authors:  Chrishne Sivapathasuntharam; Sobha Sivaprasad; Christopher Hogg; Glen Jeffery
Journal:  Neurobiol Aging       Date:  2017-01-10       Impact factor: 4.673

8.  Optical monitoring of retinal respiration in real time: 670 nm light increases the redox state of mitochondria.

Authors:  Pardis Kaynezhad; Ilias Tachtsidis; Glen Jeffery
Journal:  Exp Eye Res       Date:  2016-09-21       Impact factor: 3.467

9.  Primate retinal cones express phosphorylated tau associated with neuronal degeneration yet survive in old age.

Authors:  Asmaa Aboelnour; Jacqueline Van der Spuy; Michael Powner; Glen Jeffery
Journal:  Exp Eye Res       Date:  2017-09-30       Impact factor: 3.467

10.  Elimination of a Retinal Riboflavin Binding Protein Exacerbates Degeneration in a Model of Cone-Rod Dystrophy.

Authors:  Ayse M Genc; Mustafa S Makia; Tirthankar Sinha; Shannon M Conley; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.